We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Study to Evaluate Efficacy and Safety of DR-102 for the Prevention of Pregnancy

- Contraception | Female Contraception
- Completed

Study Title: A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy

Teva Identifier: DSG-PPS-303

ClinicalTrials.gov Identifier: NCT01178125

Study Status: Completed

Trial Condition(s): Contraception | Female Contraception

Interventions: Drug: DR-102

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

female icon for clinical trials

Key Participation Requirements

Gender: Female

Age Range: 18 Years to 40 Years

Trial Duration: 08/01/2010 - 01/01/2013

Phase: Phase 3

Study Type

Interventional